跳至主要内容
临床试验/CTRI/2024/09/073249
CTRI/2024/09/073249尚未招募3 期

A Randomized Controlled Clinical trial to evaluate the effect of Guggulvadi Churna in the management of Primary Hypothyroidism

Dr Amirtha Lakshmi T1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年9月2日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
reduction in tsh and Ft4 levels

研究概览

简要总结

Hypothyroidism is a clinical hypometabolic state which is defined by Low levels of TSH and High FT4.

It is characterised by Low metabolic rate, Hairloss, Slowened thinking capacity, weight gain.

.On the basis of symptomatology, hypothyroidism can also be established parallel to Medoroga. In Medoroga, all the channels that continuously supply nutrients to other tissues are blocked by Medas. So, further tissues

are not properly formed and only Medas is accumulated. Therefore, the patient becomes weak

and will be unable to perform any type of function

Guggulvadi Churna containing Shuddha Guggulu, Hareetaki, Vibheetaki, Amalaki, Shunti, Pippali, Maricha, Chitrakamula, Musta,Vidanga, and is indicated in Medo Vikara, Shleshma Vikaras, Madatyayam. This formulation

has Katu, Kashaya Rasa, Laghu- Ruksha Guna, Ushna Virya, Katu Vipaka, Kapha Vata

Pradhana Tridoshahara in nature. Deepana, Pachana property of the Guggulvadi Churna

helps to rekindle the suppressed Jatharagni. This Churna having Medo-Dhatwagni Vardaka

action can be highly target specific and effective in Medoroga. In-vitro and animal studies

have proven that Guggulu has thyroid stimulating activity

Some of the drugs of this Churna contains Lekhana property which helps to remove excess of Medas and Kapha obstructing the Srotases. Guggulu & Triphala being two of the ingredients, this formulation also exhibits

Rasayana property.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • TSH with in the range of 4.6 to 40 mU L FT4 less than 0.9 ng dL Anti-TPO less than 9 IU L.

排除标准

  • Low TSH, low FT4 Patients under medications such as Levothyroxine, Amiodarone, Birth control pills.
  • Patient who underwent thyroidectomy Grade 2 and 3 goitre K/C/O.
  • Hypertension Pregnant and lactating women.

结局指标

主要结局

reduction in tsh and Ft4 levels

时间窗: 46 days

次要结局

未报告次要终点

研究者

发起方
Dr Amirtha Lakshmi T
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Amirtha Lakshmi T

Sri Jayendra Saraswathi Ayurveda College & Hospital

研究点 (1)

Loading locations...

相似试验